{
    "answer": "Olympus Corporation's Consolidated Financial Results for the 1st Quarter of fiscal year 2025 indicate strong year-over-year growth in emerging markets and notably in the Endoscopic Solutions Division (ESD), achieving over 20% growth YoY. Both results for the ESD and emerging markets achieve over 20% growth year on year in Q1 FY2025.",
    "ground_truth": "over 20%",
    "rewards": [
        0,
        0
    ],
    "reward_sum": 0,
    "turns": 2,
    "search count": 1,
    "script count": 0,
    "summary count": 0,
    "context lengths": [
        850,
        2209
    ]
}